Policy, Law, Economics and Politics - Deepening Democracy through Access to Information
This privately-owned website is operated and maintained by Creamer Media
We have detected that the browser you are using is no longer supported. As a result, some content may not display correctly.
We suggest that you upgrade to the latest version of any of the following browsers:
         
close notification
24 May 2012
   
 
 
Article by: Sapa
 
 
 

The Council for Scientific and Industrial Research (CSIR) has developed a low-cost method of producing antiretrovirals (ARVs), used in the treatment of Aids.

It had filed a patent application on the new technology, the CSIR said in a statement on Monday.

"In South Africa, with the number of people requiring ARV drugs estimated at approaching one million... the local manufacturing of these drugs is an imperative," CSIR biosciences research unit director Gatsha Mazithulela said.

The challenge now was to find commercial partners willing to invest in manufacturing.

"We look forward to interesting conversations with our government and other stakeholders in making local production of ARVs a reality," he said.

 

 

Edited by: Sapa
 
 
 
 
 
  Map
 
 
 
 
 
 
 
Advertisements:
 
 
 
 
 
 
 
 
 
 
 
 
  Related social media
 
 
 
 
 
 
 
  Topics on this page
 
 
 
 
 
 
 
 
 
Online Publishers Association